Watson Robert Eugene

Average Profitability
28.95%
Insider Buys Quantity
12
Insider Buys Sum
$324,848.57
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Watson Robert Eugene

According to the SEC Form 4 filings, Watson Robert Eugene, being in a position of

  1. director at CEL-SCI Corporation,
    оver the last 12 months, has bought 20000 shares for $27,800, and sold 0 shares,
    over all time since 2020-02-26, has bought 22973 shares for $57,212, and sold 0 shares.

The largest purchase of all time was on 2011-12-28 and amounted to 45454 shares of Streamline Health Solutions, Inc. for $74,999.

Biography of Watson Robert Eugene

No biography is available at this moment.

2024-05-08PurchaseCEL-SCI Corporation
CVM
director
20,000
0.0371%
$1.39$27,800-17.63%
2021-07-06PurchaseCEL-SCI Corporation
CVM
director
1,250
0.0031%
$8.00$10,000-9.69%
2020-11-18PurchaseCEL-SCI Corporation
CVM
director
800
0.0021%
$11.77$9,416+16.45%
2020-02-26PurchaseCEL-SCI Corporation
CVM
director
923
0.0026%
$10.83$9,996+23.45%
2015-01-20PurchaseStreamline Health Solutions, Inc.
STRM
director
2,500
0.0129%
$3.54$8,842-32.85%
2014-09-19PurchaseStreamline Health Solutions, Inc.
STRM
President & CEO
5,000
0.0277%
$3.92$19,600-8.27%
2014-08-21PurchaseStreamline Health Solutions, Inc.
STRM
President & CEO
10,000
0.0528%
$4.28$42,828-14.67%
2013-04-30PurchaseStreamline Health Solutions, Inc.
STRM
President & CEO
2,750
0.0214%
$6.28$17,265+7.11%
2012-10-26PurchaseStreamline Health Solutions, Inc.
STRM
President & CEO
7,140
0.0408%
$4.16$29,702+8.01%
2011-12-28PurchaseStreamline Health Solutions, Inc.
STRM
President & CEO
45,454
0.4894%
$1.65$74,999+128.39%
2011-06-10PurchaseStreamline Health Solutions, Inc.
STRM
President & CEO
10,000
0.0964%
$1.77$17,700-6.01%
2011-04-15PurchaseStreamline Health Solutions, Inc.
STRM
President & CEO
35,000
0.3605%
$1.62$56,700+6.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.